Home / Research and experimental development on biotechnology (except medical and veterinary science)

HOLOCENE PTE. LTD.

Live CompanyUEN 201302097WLocal Company

HOLOCENE PTE. LTD. is a local company in Singapore with UEN 201302097W. It was registered on 21 Jan 2013, 13 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN201302097W
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered21 Jan 2013
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity70201 Management consultancy services
Address190 MIDDLE ROAD, #15-01, FORTUNE CENTRE, Singapore 188979
1036 companies at this address
AreaRochor · District 7 (Middle Road, Golden Mile)
Nearest stationBencoolen MRT, about 211 m
Officers7
Last annual return8 Jun 2026

Former names

  • ST PARAMOUNT

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.